rs772457274
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_177438.3(DICER1):c.4206+9_4206+17del variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00568 in 1,253,814 control chromosomes in the GnomAD database, including 102 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.017 ( 52 hom., cov: 0)
Exomes 𝑓: 0.0044 ( 50 hom. )
Consequence
DICER1
NM_177438.3 intron
NM_177438.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.918
Genes affected
DICER1 (HGNC:17098): (dicer 1, ribonuclease III) This gene encodes a protein possessing an RNA helicase motif containing a DEXH box in its amino terminus and an RNA motif in the carboxy terminus. The encoded protein functions as a ribonuclease and is required by the RNA interference and small temporal RNA (stRNA) pathways to produce the active small RNA component that represses gene expression. This protein also acts as a strong antiviral agent with activity against RNA viruses, including the Zika and SARS-CoV-2 viruses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2021]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
?
Variant 14-95099762-ACACACACAC-A is Benign according to our data. Variant chr14-95099762-ACACACACAC-A is described in ClinVar as [Likely_benign]. Clinvar id is 477186.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95099762-ACACACACAC-A is described in Lovd as [Benign].
BS1
?
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0172 (2085/121112) while in subpopulation AFR AF= 0.0474 (1733/36580). AF 95% confidence interval is 0.0455. There are 52 homozygotes in gnomad4. There are 1004 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
?
High AC in GnomAd at 2079 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DICER1 | NM_177438.3 | c.4206+9_4206+17del | intron_variant | ENST00000343455.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DICER1 | ENST00000343455.8 | c.4206+9_4206+17del | intron_variant | 1 | NM_177438.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0172 AC: 2079AN: 121006Hom.: 52 Cov.: 0
GnomAD3 genomes
?
AF:
AC:
2079
AN:
121006
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00303 AC: 699AN: 230604Hom.: 56 AF XY: 0.00249 AC XY: 313AN XY: 125578
GnomAD3 exomes
AF:
AC:
699
AN:
230604
Hom.:
AF XY:
AC XY:
313
AN XY:
125578
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00445 AC: 5039AN: 1132702Hom.: 50 AF XY: 0.00438 AC XY: 2460AN XY: 561494
GnomAD4 exome
AF:
AC:
5039
AN:
1132702
Hom.:
AF XY:
AC XY:
2460
AN XY:
561494
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0172 AC: 2085AN: 121112Hom.: 52 Cov.: 0 AF XY: 0.0172 AC XY: 1004AN XY: 58326
GnomAD4 genome
?
AF:
AC:
2085
AN:
121112
Hom.:
Cov.:
0
AF XY:
AC XY:
1004
AN XY:
58326
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:5
Benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Aug 15, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Aug 03, 2021 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 07, 2019 | See Variant Classification Assertion Criteria. - |
DICER1-related tumor predisposition Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Dec 07, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at